{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:04:06Z","timestamp":1789495446522,"version":"build-2803163510"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T00:00:00Z","timestamp":1666137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T00:00:00Z","timestamp":1666137600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["19TPA34910111"],"award-info":[{"award-number":["19TPA34910111"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Biomed Eng"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s10439-022-03094-w","type":"journal-article","created":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T20:02:46Z","timestamp":1666209766000},"page":"1734-1749","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Advances in Targeting ACE2 for Developing COVID-19 Therapeutics"],"prefix":"10.1007","volume":"50","author":[{"given":"Sanika","family":"Suvarnapathaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelina","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murugan","family":"Ramalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4258-844X","authenticated-orcid":false,"given":"Gulden","family":"Camci-Unal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,19]]},"reference":[{"key":"3094_CR1","unstructured":"Coronavirus (COVID-19) Update. FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19. US Food and Drug Administration, 2020."},{"key":"3094_CR2","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41392-020-00374-6","volume":"5","author":"TM Abd El-Aziz","year":"2020","unstructured":"Abd El-Aziz, T. M., A. Al-Sabi, and J. D. Stockand. Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID-19. Signal Transduc. Target Therapy. 5:258\u2013258, 2020","journal-title":"Signal Transduc. Target Therapy"},{"key":"3094_CR3","doi-asserted-by":"publisher","first-page":"552909","DOI":"10.3389\/fimmu.2020.552909","volume":"11","author":"Z Abdelrahman","year":"2020","unstructured":"Abdelrahman, Z., M. Li, and X. Wang. Comparative review of SARS-CoV-2, SARS-CoV, MERS-CoV, and influenza a respiratory viruses. Front. Immunol. 11:552909\u2013552909, 2020","journal-title":"Front. Immunol."},{"key":"3094_CR4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jare.2020.11.013","volume":"30","author":"T Abu-Izneid","year":"2021","unstructured":"Abu-Izneid, T., N. AlHajri, A. M. Ibrahim, M. N. Javed, K. M. Salem, F. H. Pottoo, and M. A. Kamal. Micro-RNAs in the regulation of immune response against SARS CoV-2 and other viral infections. J. Adv. Res. 30:133\u2013145, 2021","journal-title":"J. Adv. Res."},{"key":"3094_CR5","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1183\/13993003.01123-2020","volume":"56","author":"JA Aguiar","year":"2020","unstructured":"Aguiar, J. A., B. J. Tremblay, M. J. Mansfield, O. Woody, B. Lobb, A. Banerjee, A. Chandiramohan, N. Tiessen, Q. Cao, and A. Dvorkin-Gheva. Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue. Eur. Respir. J. 56:270, 2020","journal-title":"Eur. Respir. J."},{"key":"3094_CR6","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1080\/1061186X.2020.1797754","volume":"28","author":"S Akhtar","year":"2020","unstructured":"Akhtar, S., I. F. Benter, M. I. Danjuma, S. A. Doi, S. S. Hasan, and A. M. Habib. Pharmacotherapy in COVID-19 patients: a review of ACE2-raising drugs and their clinical safety. J. Drug Target. 28:683\u2013699, 2020","journal-title":"J. Drug Target."},{"key":"3094_CR7","first-page":"7","volume":"5","author":"S Alexandar","year":"2021","unstructured":"Alexandar, S., M. Ravisankar, R. S. Kumar, and K. Jakkan. A comprehensive review on Covid-19 Delta variant. Int. J. Pharmacol. Clin. Res. 5:7, 2021","journal-title":"Int. J. Pharmacol. Clin. Res."},{"key":"3094_CR8","doi-asserted-by":"crossref","unstructured":"Berry J. D., K. Hay, J. M. Rini, M. Yu, L. Wang, F. A. Plummer, C. R. Corbett, and A. Andonov. Neutralizing epitopes of the SARS-CoV S-protein cluster independent of repertoire, antigen structure or mAb technology. In: MAbs. Taylor & Francis, 2010, pp. 53\u201366.","DOI":"10.4161\/mabs.2.1.10788"},{"key":"3094_CR9","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s10096-020-04138-6","volume":"40","author":"S Beyerstedt","year":"2021","unstructured":"Beyerstedt, S., E. B. Casaro, and \u00c9. B. Rangel. COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection. Eur. J. Clin. Microbiol. Infect. Dis. 40:905\u2013919, 2021","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"3094_CR10","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/jmv.25736","volume":"92","author":"M Bhattacharya","year":"2020","unstructured":"Bhattacharya, M., A. R. Sharma, P. Patra, P. Ghosh, G. Sharma, B. C. Patra, S.-S. Lee, and C. Chakraborty. Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): immunoinformatics approach. J. Med. Virol. 92:618\u2013631, 2020","journal-title":"J. Med. Virol."},{"key":"3094_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.apsb.2020.10.006","volume":"11","author":"J Bian","year":"2021","unstructured":"Bian, J., and Z. Li. Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator. Acta Pharmac. Sin. B. 11:1\u201312, 2021","journal-title":"Acta Pharmac. Sin. B"},{"key":"3094_CR12","doi-asserted-by":"publisher","first-page":"6641","DOI":"10.1073\/pnas.0401939101","volume":"101","author":"H Bisht","year":"2004","unstructured":"Bisht, H., A. Roberts, L. Vogel, A. Bukreyev, P. L. Collins, B. R. Murphy, K. Subbarao, and B. Moss. Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice. Proc. Natl. Acad. Sci. 101:6641\u20136646, 2004","journal-title":"Proc. Natl. Acad. Sci."},{"key":"3094_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/985408","volume":"2014","author":"E Bronze-da-Rocha","year":"2014","unstructured":"Bronze-da-Rocha, E. MicroRNAs expression profiles in cardiovascular diseases. BioMed Res. Int. 2014:1\u201323, 2014","journal-title":"BioMed Res. Int."},{"key":"3094_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ahj.2020.11.003","volume":"233","author":"JA Brooksbank","year":"2021","unstructured":"Brooksbank, J. A., S. J. Greene, H. M. Harris, A. Stebbins, M. Fiuzat, D. J. Whellan, B. Alhanti, W. E. Kraus, I. L. Pi\u00f1a, and C. M. O\u2019Connor. Beta-blocker and ACE-inhibitor dosing as a function of body surface area: from the HF-ACTION trial. Am. Heart J. 233:1\u20134, 2021","journal-title":"Am. Heart J."},{"key":"3094_CR15","doi-asserted-by":"publisher","first-page":"649","DOI":"10.2217\/rme.14.35","volume":"9","author":"E Buzhor","year":"2014","unstructured":"Buzhor, E., L. Leshansky, J. Blumenthal, H. Barash, D. Warshawsky, Y. Mazor, and R. Shtrichman. Cell-based therapy approaches: the hope for incurable diseases. Regener. Med. 9:649\u2013672, 2014","journal-title":"Regener. Med."},{"key":"3094_CR16","doi-asserted-by":"publisher","first-page":"971","DOI":"10.3390\/antiox10060971","volume":"10","author":"N C\u00e1rdenas-Rodr\u00edguez","year":"2021","unstructured":"C\u00e1rdenas-Rodr\u00edguez, N., C. Bandala, A. Vanoye-Carlo, I. Ignacio-Mej\u00eda, S. G\u00f3mez-Manzo, E. Y. Hern\u00e1ndez-Cruz, J. Pedraza-Chaverri, L. Carmona-Aparicio, and B. Hern\u00e1ndez-Ochoa. Use of antioxidants for the neuro-therapeutic management of COVID-19. Antioxidants. 10:971, 2021","journal-title":"Antioxidants"},{"key":"3094_CR17","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1080\/22221751.2020.1719902","volume":"9","author":"JF Chan","year":"2020","unstructured":"Chan, J. F., K. H. Kok, Z. Zhu, H. Chu, K. K. To, S. Yuan, and K. Y. Yuen. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg. Microbes Infect. 9:221\u2013236, 2020","journal-title":"Emerg. Microbes Infect."},{"key":"3094_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/896861","volume":"215","author":"L-J Chen","year":"2015","unstructured":"Chen, L.-J., R. Xu, H.-M. Yu, Q. Chang, and J.-C. Zhong. The ACE2\/apelin signaling, microRNAs, and hypertension. Int. J. Hypertens. 215:1\u20136, 2015","journal-title":"Int. J. Hypertens."},{"key":"3094_CR19","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41392-021-00740-y","volume":"6","author":"Y Chen","year":"2021","unstructured":"Chen, Y., Y.-N. Zhang, R. Yan, G. Wang, Y. Zhang, Z.-R. Zhang, Y. Li, J. Ou, W. Chu, Z. Liang, Y. Wang, Y.-L. Chen, G. Chen, Q. Wang, Q. Zhou, B. Zhang, and C. Wang. ACE2-targeting monoclonal antibody as potent and broad-spectrum coronavirus blocker. Signal Transduc. Target. Therapy. 6:315, 2021","journal-title":"Signal Transduc. Target. Therapy"},{"key":"3094_CR20","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/S1474-4422(11)70305-2","volume":"11","author":"P Connick","year":"2012","unstructured":"Connick, P., M. Kolappan, C. Crawley, D. J. Webber, R. Patani, A. W. Michell, M.-Q. Du, S.-L. Luan, D. R. Altmann, A. J. Thompson, A. Compston, M. A. Scott, D. H. Miller, and S. Chandran. Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study. Lancet Neurol. 11:150\u2013156, 2012","journal-title":"Lancet Neurol."},{"key":"3094_CR21","doi-asserted-by":"publisher","first-page":"301","DOI":"10.2217\/fvl-2020-0389","volume":"16","author":"M Fani","year":"2021","unstructured":"Fani, M., M. Zandi, S. Ebrahimi, S. Soltani, and S. Abbasi. The role of miRNAs in COVID-19 disease. Fut. Virol. 16:301\u2013306, 2021","journal-title":"Fut. Virol."},{"key":"3094_CR22","doi-asserted-by":"publisher","first-page":"37721","DOI":"10.1038\/srep37721","volume":"6","author":"MH Fazil","year":"2016","unstructured":"Fazil, M. H., S. T. Ong, M. L. Chalasani, J. H. Low, A. Kizhakeyil, A. Mamidi, C. F. Lim, G. D. Wright, R. Lakshminarayanan, D. Kelleher, and N. K. Verma. GapmeR cellular internalization by macropinocytosis induces sequence-specific gene silencing in human primary T-cells. Sci. Rep. 6:37721, 2016","journal-title":"Sci. Rep."},{"key":"3094_CR23","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","volume":"111","author":"CM Ferrario","year":"2005","unstructured":"Ferrario, C. M., J. Jessup, M. C. Chappell, D. B. Averill, K. B. Brosnihan, E. A. Tallant, D. I. Diz, and P. E. Gallagher. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation. 111:2605\u20132610, 2005","journal-title":"Circulation"},{"key":"3094_CR24","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1161\/CIRCRESAHA.120.317015","volume":"126","author":"M Gheblawi","year":"2020","unstructured":"Gheblawi, M., K. Wang, A. Viveiros, Q. Nguyen, J.-C. Zhong, A. J. Turner, M. K. Raizada, M. B. Grant, and G. Y. Oudit. Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2. Circ. Res. 126:1456\u20131474, 2020","journal-title":"Circ. Res."},{"key":"3094_CR25","doi-asserted-by":"publisher","first-page":"4030","DOI":"10.4049\/jimmunol.173.6.4030","volume":"173","author":"WG Glass","year":"2004","unstructured":"Glass, W. G., K. Subbarao, B. Murphy, and P. M. Murphy. Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice. J. Immunol. 173:4030\u20134039, 2004","journal-title":"J. Immunol."},{"key":"3094_CR26","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1086\/427242","volume":"191","author":"TC Greenough","year":"2005","unstructured":"Greenough, T. C., G. J. Babcock, A. Roberts, H. J. Hernandez, W. D. Thomas Jr., J. A. Coccia, R. F. Graziano, M. Srinivasan, I. Lowy, R. W. Finberg, K. Subbarao, L. Vogel, M. Somasundaran, K. Luzuriaga, J. L. Sullivan, and D. M. Ambrosino. Development and characterization of a severe acute respiratory syndrome\u2014associated coronavirus\u2014neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice. J. Infect. Dis. 191:507\u2013514, 2005","journal-title":"J. Infect. Dis."},{"key":"3094_CR27","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/path.1570","volume":"203","author":"I Hamming","year":"2004","unstructured":"Hamming, I., W. Timens, M. Bulthuis, A. Lely, G. Navis, and H. van Goor. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 203:631\u2013637, 2004","journal-title":"J. Pathol."},{"key":"3094_CR28","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1021\/acsptsci.0c00161","volume":"3","author":"QM Hanson","year":"2020","unstructured":"Hanson, Q. M., K. M. Wilson, M. Shen, Z. Itkin, R. T. Eastman, P. Shinn, and M. D. Hall. Targeting ACE2\u2013RBD interaction as a platform for COVID-19 therapeutics: development and drug-repurposing screen of an AlphaLISA proximity assay. ACS Pharmacol. Transl. Sci. 3:1352\u20131360, 2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"3094_CR29","first-page":"1136","volume":"60","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann, M., H. Kleine-Weber, N. Kr\u00fcger, M. M\u00fcller, C. Drosten, and S. P\u00f6hlmann. The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells. BioRxiv. 60:1136, 2020","journal-title":"BioRxiv"},{"key":"3094_CR30","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/sctm.17-0278","volume":"7","author":"S Hu","year":"2018","unstructured":"Hu, S., J. Park, A. Liu, J. Lee, X. Zhang, Q. Hao, and J.-W. Lee. Mesenchymal stem cell microvesicles restore protein permeability across primary cultures of injured human lung microvascular endothelial cells. STEM CELLS Transl. Med. 7:615\u2013624, 2018","journal-title":"STEM CELLS Transl. Med."},{"key":"3094_CR31","doi-asserted-by":"publisher","first-page":"H1013","DOI":"10.1152\/ajpheart.00068.2005","volume":"289","author":"M Igase","year":"2005","unstructured":"Igase, M., W. B. Strawn, P. E. Gallagher, R. L. Geary, and C. M. Ferrario. Angiotensin II AT1 receptors regulate ACE2 and angiotensin-(1\u20137) expression in the aorta of spontaneously hypertensive rats. Am. J. Physiol.-Heart Circ. Physiol. 289:H1013\u2013H1019, 2005","journal-title":"Am. J. Physiol.-Heart Circ. Physiol."},{"key":"3094_CR32","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1161\/01.HYP.0000124667.34652.1a","volume":"43","author":"Y Ishiyama","year":"2004","unstructured":"Ishiyama, Y., P. E. Gallagher, D. B. Averill, E. A. Tallant, K. B. Brosnihan, and C. M. Ferrario. Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors. Hypertension. 43:970\u2013976, 2004","journal-title":"Hypertension"},{"key":"3094_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","volume":"23","author":"CB Jackson","year":"2022","unstructured":"Jackson, C. B., M. Farzan, B. Chen, and H. Choe. Mechanisms of SARS-CoV-2 entry into cells. Nat. Rev. Mol. Cell Biol. 23:3\u201320, 2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"3094_CR34","unstructured":"Janeway C., P. Travers, M. Walport, and M. Shlomchik. Immunologists' toolbox. Immunobiology, 5th ed. New York: Garland Science Publishing, pp. 613\u2013660, 2001."},{"key":"3094_CR35","doi-asserted-by":"publisher","first-page":"H2166","DOI":"10.1152\/ajpheart.00061.2006","volume":"291","author":"JA Jessup","year":"2006","unstructured":"Jessup, J. A., P. E. Gallagher, D. B. Averill, K. B. Brosnihan, E. A. Tallant, M. C. Chappell, and C. M. Ferrario. Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats. Am. J. Physiol. Heart Circ. Physiol. 291:H2166\u2013H2172, 2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"3094_CR36","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1165\/rcmb.2020-0322PS","volume":"64","author":"H Jia","year":"2021","unstructured":"Jia, H., E. Neptune, and H. Cui. Targeting ACE2 for COVID-19 therapy: opportunities and challenges. Am. J. Respir. Cell Mol. Biol. 64:416\u2013425, 2021","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"3094_CR37","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2147\/VHRM.S355410","volume":"18","author":"M Kar","year":"2022","unstructured":"Kar, M. Vascular dysfunction and its cardiovascular consequences during and after COVID-19 infection: a narrative review. Vasc. Health Risk Manag. 18:105, 2022","journal-title":"Vasc. Health Risk Manag."},{"key":"3094_CR38","doi-asserted-by":"publisher","first-page":"2000858","DOI":"10.1183\/13993003.00858-2020","volume":"55","author":"M Khoury","year":"2020","unstructured":"Khoury, M., J. Cuenca, F. F. Cruz, F. E. Figueroa, P. R. M. Rocco, and D. J. Weiss. Current status of cell-based therapies for respiratory virus infections: applicability to COVID-19. Eur. Respir. J. 55:2000858, 2020","journal-title":"Eur. Respir. J."},{"key":"3094_CR39","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/256495a0","volume":"256","author":"G K\u00f6hler","year":"1975","unstructured":"K\u00f6hler, G., and C. Milstein. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 256:495\u2013497, 1975","journal-title":"Nature"},{"key":"3094_CR40","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1002\/stem.544","volume":"28","author":"A Krasnodembskaya","year":"2010","unstructured":"Krasnodembskaya, A., Y. Song, X. Fang, N. Gupta, V. Serikov, J.-W. Lee, and M. A. Matthay. Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37. Stem Cells. 28:2229\u20132238, 2010","journal-title":"Stem Cells"},{"key":"3094_CR41","unstructured":"Lantigua D. M. C., and G. C. Unal. Point of care platform for detection of SARS-CoV-2\/COVID-19. J Infect Dis Ther 2022."},{"key":"3094_CR42","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1164\/rccm.201206-0990OC","volume":"187","author":"JW Lee","year":"2013","unstructured":"Lee, J. W., A. Krasnodembskaya, D. H. McKenna, Y. Song, J. Abbott, and M. A. Matthay. Therapeutic effects of human mesenchymal stem cells in ex vivo human lungs injured with live bacteria. Am. J. Respir. Critical Care Med. 187:751\u2013760, 2013","journal-title":"Am. J. Respir. Critical Care Med."},{"key":"3094_CR43","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.stem.2009.05.003","volume":"5","author":"RH Lee","year":"2009","unstructured":"Lee, R. H., A. A. Pulin, M. J. Seo, D. J. Kota, J. Ylostalo, B. L. Larson, L. Semprun-Prieto, P. Delafontaine, and D. J. Prockop. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell. 5:54\u201363, 2009","journal-title":"Cell Stem Cell"},{"key":"3094_CR44","doi-asserted-by":"publisher","first-page":"216","DOI":"10.14336\/AD.2020.0228","volume":"11","author":"Z Leng","year":"2020","unstructured":"Leng, Z., R. Zhu, W. Hou, Y. Feng, Y. Yang, Q. Han, G. Shan, F. Meng, D. Du, S. Wang, J. Fan, W. Wang, L. Deng, H. Shi, H. Li, Z. Hu, F. Zhang, J. Gao, H. Liu, X. Li, Y. Zhao, K. Yin, X. He, Z. Gao, Y. Wang, B. Yang, R. Jin, I. Stambler, L. W. Lim, H. Su, A. Moskalev, A. Cano, S. Chakrabarti, K.-J. Min, G. Ellison-Hughes, C. Caruso, K. Jin, and R. C. Zhao. Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia. Aging Dis. 11:216\u2013228, 2020","journal-title":"Aging Dis."},{"key":"3094_CR45","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1080\/13543776.2017.1272572","volume":"27","author":"Y-Y Li","year":"2017","unstructured":"Li, Y.-Y., J. Fang, and G.-Z. Ao. Cathepsin B and L inhibitors: a patent review (2010-present). Expert Opin. Therap. Patents. 27:643\u2013656, 2017","journal-title":"Expert Opin. Therap. Patents"},{"key":"3094_CR46","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1634\/stemcells.2007-0454","volume":"26","author":"F Liotta","year":"2008","unstructured":"Liotta, F., R. Angeli, L. Cosmi, L. Fil\u00ec, C. Manuelli, F. Frosali, B. Mazzinghi, L. Maggi, A. Pasini, V. Lisi, V. Santarlasci, L. Consoloni, M. L. Angelotti, P. Romagnani, P. Parronchi, M. Krampera, E. Maggi, S. Romagnani, and F. Annunziato. Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing notch signaling. STEM CELLS. 26:279\u2013289, 2008","journal-title":"STEM CELLS"},{"key":"3094_CR47","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41591-020-0897-1","volume":"26","author":"Q-X Long","year":"2020","unstructured":"Long, Q.-X., B.-Z. Liu, H.-J. Deng, G.-C. Wu, K. Deng, Y.-K. Chen, P. Liao, J.-F. Qiu, Y. Lin, X.-F. Cai, D.-Q. Wang, Y. Hu, J.-H. Ren, N. Tang, Y.-Y. Xu, L.-H. Yu, Z. Mo, F. Gong, X.-L. Zhang, W.-G. Tian, L. Hu, X.-X. Zhang, J.-L. Xiang, H.-X. Du, H.-W. Liu, C.-H. Lang, X.-H. Luo, S.-B. Wu, X.-P. Cui, Z. Zhou, M.-M. Zhu, J. Wang, C.-J. Xue, X.-F. Li, L. Wang, Z.-J. Li, K. Wang, C.-C. Niu, Q.-J. Yang, X.-J. Tang, Y. Zhang, X.-M. Liu, J.-J. Li, D.-C. Zhang, F. Zhang, P. Liu, J. Yuan, Q. Li, J.-L. Hu, J. Chen, and A.-L. Huang. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat. Med. 26:845\u2013848, 2020","journal-title":"Nat. Med."},{"key":"3094_CR48","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.yjmcc.2020.08.017","volume":"148","author":"D Lu","year":"2020","unstructured":"Lu, D., S. Chatterjee, K. Xiao, I. Riedel, Y. Wang, R. Foo, C. B\u00e4r, and T. Thum. MicroRNAs targeting the SARS-CoV-2 entry receptor ACE2 in cardiomyocytes. J. Mol. Cell. Cardiol. 148:46\u201349, 2020","journal-title":"J. Mol. Cell. Cardiol."},{"key":"3094_CR49","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","volume":"395","author":"R Lu","year":"2020","unstructured":"Lu, R., X. Zhao, J. Li, P. Niu, B. Yang, H. Wu, W. Wang, H. Song, B. Huang, N. Zhu, Y. Bi, X. Ma, F. Zhan, L. Wang, T. Hu, H. Zhou, Z. Hu, W. Zhou, L. Zhao, J. Chen, Y. Meng, J. Wang, Y. Lin, J. Yuan, Z. Xie, J. Ma, W. J. Liu, D. Wang, W. Xu, E. C. Holmes, G. F. Gao, G. Wu, W. Chen, W. Shi, and W. Tan. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 395:565\u2013574, 2020","journal-title":"Lancet"},{"key":"3094_CR50","doi-asserted-by":"publisher","first-page":"715","DOI":"10.2353\/ajpath.2007.070166","volume":"171","author":"MM Markiewski","year":"2007","unstructured":"Markiewski, M. M., and J. D. Lambris. The role of complement in inflammatory diseases from behind the scenes into the spotlight. Am. J. Pathol. 171:715\u2013727, 2007","journal-title":"Am. J. Pathol."},{"key":"3094_CR51","doi-asserted-by":"publisher","first-page":"100123","DOI":"10.1016\/j.onehlt.2020.100123","volume":"9","author":"AM Marty","year":"2020","unstructured":"Marty, A. M., and M. K. Jones. The novel coronavirus (SARS-CoV-2) is a one health issue. One Health. 9:100123, 2020","journal-title":"One Health"},{"key":"3094_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2021.622898","author":"HM Mengist","year":"2021","unstructured":"Mengist, H. M., T. Dilnessa, and T. Jin. Structural basis of potential inhibitors targeting SARS-CoV-2 main protease. Front. Chem. 2021. https:\/\/doi.org\/10.3389\/fchem.2021.622898","journal-title":"Front. Chem."},{"key":"3094_CR53","first-page":"1","volume":"18","author":"RK Mohapatra","year":"2022","unstructured":"Mohapatra, R. K., N. A. El-Shall, R. Tiwari, F. Nainu, V. Kandi, A. K. Sarangi, T. A. Mohammed, P. A. Desingu, C. Chakraborty, and K. Dhama. Need of booster vaccine doses to counteract the emergence of SARS-CoV-2 variants in the context of the Omicron variant and increasing COVID-19 cases: an update. Hum. Vacc. Immunotherap. 18:1\u20139, 2022","journal-title":"Hum. Vacc. Immunotherap."},{"key":"3094_CR54","doi-asserted-by":"publisher","first-page":"e1009225","DOI":"10.1371\/journal.ppat.1009225","volume":"17","author":"N Murgolo","year":"2021","unstructured":"Murgolo, N., A. G. Therien, B. Howell, D. Klein, K. Koeplinger, L. A. Lieberman, G. C. Adam, J. Flynn, P. McKenna, G. Swaminathan, D. J. Hazuda, and D. B. Olsen. SARS-CoV-2 tropism, entry, replication, and propagation: considerations for drug discovery and development. PLOS Pathogens. 17:e1009225, 2021","journal-title":"PLOS Pathogens"},{"key":"3094_CR55","doi-asserted-by":"publisher","first-page":"165878","DOI":"10.1016\/j.bbadis.2020.165878","volume":"1866","author":"AAT Naqvi","year":"2020","unstructured":"Naqvi, A. A. T., K. Fatima, T. Mohammad, U. Fatima, I. K. Singh, A. Singh, S. M. Atif, G. Hariprasad, G. M. Hasan, and M. I. Hassan. Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: structural genomics approach. Biochim. Biophys. Acta. 1866:165878, 2020","journal-title":"Biochim. Biophys. Acta."},{"key":"3094_CR56","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s42003-022-03090-9","volume":"5","author":"A Narayanan","year":"2022","unstructured":"Narayanan, A., M. Narwal, S. A. Majowicz, C. Varricchio, S. A. Toner, C. Ballatore, A. Brancale, K. S. Murakami, and J. Jose. Identification of SARS-CoV-2 inhibitors targeting Mpro and PLpro using in-cell-protease assay. Commun. Biol. 5:169, 2022","journal-title":"Commun. Biol."},{"key":"3094_CR57","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1001\/jama.2020.7603","volume":"324","author":"EA Nardell","year":"2020","unstructured":"Nardell, E. A., and R. R. Nathavitharana. Airborne spread of SARS-CoV-2 and a potential role for air disinfection. JAMA. 324:141\u2013142, 2020","journal-title":"JAMA"},{"key":"3094_CR58","doi-asserted-by":"publisher","first-page":"e0248348","DOI":"10.1371\/journal.pone.0248348","volume":"16","author":"SN Neerukonda","year":"2021","unstructured":"Neerukonda, S. N., R. Vassell, R. Herrup, S. Liu, T. Wang, K. Takeda, Y. Yang, T.-L. Lin, W. Wang, and C. D. Weiss. Establishment of a well-characterized SARS-CoV-2 lentiviral pseudovirus neutralization assay using 293T cells with stable expression of ACE2 and TMPRSS2. PLoS One. 16:e0248348, 2021","journal-title":"PLoS One"},{"key":"3094_CR59","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3390\/diagnostics10110905","volume":"10","author":"NN Nguyen","year":"2020","unstructured":"Nguyen, N. N., C. McCarthy, D. Lantigua, and G. Camci-Unal. Development of diagnostic tests for detection of SARS-CoV-2. Diagnostics. 10:905, 2020","journal-title":"Diagnostics"},{"key":"3094_CR60","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1161\/01.HYP.0000237862.94083.45","volume":"48","author":"MP Ocaranza","year":"2006","unstructured":"Ocaranza, M. P., I. Godoy, J. E. Jalil, M. Varas, P. Collantes, M. Pinto, M. Roman, C. Ramirez, M. Copaja, and G. Diaz-Araya. Enalapril attenuates downregulation of angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat. Hypertension. 48:572\u2013578, 2006","journal-title":"Hypertension"},{"key":"3094_CR61","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.7423","author":"M Pal","year":"2020","unstructured":"Pal, M., G. Berhanu, C. Desalegn, and V. Kandi. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): an update. Cureus. 2020. https:\/\/doi.org\/10.7759\/cureus.7423","journal-title":"Cureus"},{"key":"3094_CR62","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.biopha.2018.05.148","volume":"105","author":"S Patel","year":"2018","unstructured":"Patel, S., A. Homaei, H. R. El-Seedi, and N. Akhtar. Cathepsins: proteases that are vital for survival but can also be fatal. Biomed. Pharmacotherapy. 105:526\u2013532, 2018","journal-title":"Biomed. Pharmacotherapy"},{"key":"3094_CR63","doi-asserted-by":"publisher","first-page":"198631","DOI":"10.1016\/j.virusres.2021.198631","volume":"308","author":"S Paul","year":"2022","unstructured":"Paul, S., L. A. Bravo-V\u00e1zquez, P. R. Reyes-P\u00e9rez, C. Estrada-Meza, R. A. Aponte-Alburquerque, S. Pathak, A. Banerjee, A. Bandyopadhyay, S. Chakraborty, and A. Srivastava. The role of microRNAs in solving COVID-19 puzzle from infection to therapeutics: a mini-review. Virus Res. 308:198631, 2022","journal-title":"Virus Res."},{"key":"3094_CR64","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.tibs.2021.06.001","volume":"46","author":"R Peng","year":"2021","unstructured":"Peng, R., L.-A. Wu, Q. Wang, J. Qi, and G. F. Gao. Cell entry by SARS-CoV-2. Trends Biochem. Sci. 46:848\u2013860, 2021","journal-title":"Trends Biochem. Sci."},{"key":"3094_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fviro.2021.815388","author":"M Pizzato","year":"2022","unstructured":"Pizzato, M., C. Baraldi, G. B. Sopetto, D. Finozzi, C. Gentile, M. D. Gentile, R. Marconi, D. Paladino, A. Raoss, and I. Riedmiller. SARS-CoV-2 and the host cell: a tale of interactions. Front. Virol. 2022. https:\/\/doi.org\/10.3389\/fviro.2021.815388","journal-title":"Front. Virol."},{"key":"3094_CR66","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1021\/acs.jmedchem.0c01467","volume":"65","author":"R Raghuvanshi","year":"2021","unstructured":"Raghuvanshi, R., and S. B. Bharate. Recent developments in the use of kinase inhibitors for management of viral Infections. J. Med. Chem. 65:893\u2013921, 2021","journal-title":"J. Med. Chem."},{"key":"3094_CR67","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.3390\/molecules25102271","volume":"25","author":"N Rahman","year":"2020","unstructured":"Rahman, N., Z. Basharat, M. Yousuf, G. Castaldo, L. Rastrelli, and H. Khan. Virtual screening of natural products against type II transmembrane serine protease (TMPRSS2), the priming agent of coronavirus 2 (SARS-CoV-2). Molecules. 25:2271, 2020","journal-title":"Molecules"},{"key":"3094_CR68","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s00425-013-2019-5","volume":"239","author":"S Saurabh","year":"2014","unstructured":"Saurabh, S., A. S. Vidyarthi, and D. Prasad. RNA interference: concept to reality in crop improvement. Planta. 239:543\u2013564, 2014","journal-title":"Planta"},{"key":"3094_CR69","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1002\/jcp.30032","volume":"236","author":"S Seyedpour","year":"2021","unstructured":"Seyedpour, S., B. Khodaei, A. H. Loghman, N. Seyedpour, M. F. Kisomi, M. Balibegloo, S. S. Nezamabadi, B. Gholami, A. Saghazadeh, and N. Rezaei. Targeted therapy strategies against SARS-CoV-2 cell entry mechanisms: a systematic review of in vitro and in vivo studies. J. Cell. Physiol. 236:2364\u20132392, 2021","journal-title":"J. Cell. Physiol."},{"key":"3094_CR70","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.3389\/fimmu.2020.01949","volume":"11","author":"VK Shah","year":"2020","unstructured":"Shah, V. K., P. Firmal, A. Alam, D. Ganguly, and S. Chattopadhyay. Overview of immune response during SARS-CoV-2 infection: lessons from the past. Front. Immunol. 11:1949, 2020","journal-title":"Front. Immunol."},{"key":"3094_CR71","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1093\/glycob\/cwaa101","volume":"31","author":"A Shajahan","year":"2021","unstructured":"Shajahan, A., S. Archer-Hartmann, N. T. Supekar, A. S. Gleinich, C. Heiss, and P. Azadi. Comprehensive characterization of N-and O-glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2. Glycobiology. 31:410\u2013424, 2021","journal-title":"Glycobiology"},{"key":"3094_CR72","doi-asserted-by":"publisher","first-page":"202003138","DOI":"10.1073\/pnas.2003138117","volume":"117","author":"J Shang","year":"2020","unstructured":"Shang, J., Y. Wan, C. Luo, G. Ye, Q. Geng, A. Auerbach, and F. Li. Cell entry mechanisms of SARS-CoV-2. Proc. Natl. Acad. Sci. 117:202003138, 2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"3094_CR73","doi-asserted-by":"publisher","first-page":"11727","DOI":"10.1073\/pnas.2003138117","volume":"117","author":"J Shang","year":"2020","unstructured":"Shang, J., Y. Wan, C. Luo, G. Ye, Q. Geng, A. Auerbach, and F. Li. Cell entry mechanisms of SARS-CoV-2. Proc. Natl. Acad. Sci. 117:11727\u201311734, 2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"3094_CR74","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41541-020-0170-0","volume":"5","author":"W Shang","year":"2020","unstructured":"Shang, W., Y. Yang, Y. Rao, and X. Rao. The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines. NPJ Vacc. 5:18, 2020","journal-title":"NPJ Vacc."},{"key":"3094_CR75","first-page":"10","volume":"38","author":"B Shanmugaraj","year":"2020","unstructured":"Shanmugaraj, B., K. Siriwattananon, K. Wangkanont, and W. Phoolcharoen. Perspectives on monoclonal antibody therapy as potential therapeutic intervention for coronavirus disease-19 (COVID-19). Asian Pac. J. Allergy Immunol. 38:10\u201318, 2020","journal-title":"Asian Pac. J. Allergy Immunol."},{"key":"3094_CR76","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.3390\/s18092838","volume":"18","author":"AT Singh","year":"2018","unstructured":"Singh, A. T., D. Lantigua, A. Meka, S. Taing, M. Pandher, and G. Camci-Unal. based sensors: emerging themes and applications. Sensors. 18:2838, 2018","journal-title":"Sensors"},{"key":"3094_CR77","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s00592-020-01539-z","volume":"57","author":"SB Solerte","year":"2020","unstructured":"Solerte, S. B., A. Di Sabatino, M. Galli, and P. Fiorina. Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19. Acta Diabetol. 57:779\u2013783, 2020","journal-title":"Acta Diabetol"},{"key":"3094_CR78","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1007\/s11427-014-4698-y","volume":"57","author":"X Song","year":"2014","unstructured":"Song, X., D. Shan, J. Chen, and Q. Jing. miRNAs and lncRNAs in vascular injury and remodeling. Sci. China Life Sci. 57:826\u2013835, 2014","journal-title":"Sci. China Life Sci."},{"key":"3094_CR79","doi-asserted-by":"publisher","first-page":"e3330","DOI":"10.1002\/dmrr.3330","volume":"36","author":"R Strollo","year":"2020","unstructured":"Strollo, R., and P. Pozzilli. DPP4 inhibition: preventing SARS-CoV-2 infection and\/or progression of COVID-19? Diabetes\/Metab. Res. Rev. 36:e3330, 2020","journal-title":"Diabetes\/Metab. Res. Rev."},{"key":"3094_CR80","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1073\/pnas.0307140101","volume":"101","author":"J Sui","year":"2004","unstructured":"Sui, J., W. Li, A. Murakami, A. Tamin, L. J. Matthews, S. K. Wong, M. J. Moore, A. S. Tallarico, M. Olurinde, H. Choe, L. J. Anderson, W. J. Bellini, M. Farzan, and W. A. Marasco. Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association. Proc. Natl. Acad. Sci. USA. 101:2536\u20132541, 2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"3094_CR81","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41423-020-0400-4","volume":"17","author":"W Tai","year":"2020","unstructured":"Tai, W., L. He, X. Zhang, J. Pu, D. Voronin, S. Jiang, Y. Zhou, and L. Du. Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine. Cell. Mol. Immunol. 17:613\u2013620, 2020","journal-title":"Cell. Mol. Immunol."},{"key":"3094_CR82","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/s41586-022-04532-4","volume":"604","author":"S Temmam","year":"2022","unstructured":"Temmam, S., K. Vongphayloth, E. Baquero, S. Munier, M. Bonomi, B. Regnault, B. Douangboubpha, Y. Karami, D. Chr\u00e9tien, and D. Sanamxay. Bat coronaviruses related to SARS-CoV-2 and infectious for human cells. Nature. 604:330\u2013336, 2022","journal-title":"Nature"},{"key":"3094_CR83","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","volume":"19","author":"P V\u2019kovski","year":"2021","unstructured":"V\u2019kovski, P., A. Kratzel, S. Steiner, H. Stalder, and V. Thiel. Coronavirus biology and replication: implications for SARS-CoV-2. Nat. Rev. Microbiol. 19:155\u2013170, 2021","journal-title":"Nat. Rev. Microbiol."},{"key":"3094_CR84","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.3389\/fphar.2020.01161","volume":"11","author":"I Valencia","year":"2020","unstructured":"Valencia, I., C. Peir\u00f3, \u00d3. Lorenzo, C. F. S\u00e1nchez-Ferrer, J. Eckel, and T. Romacho. DPP4 and ACE2 in diabetes and COVID-19: therapeutic targets for cardiovascular complications? Front. Pharmacol. 11:1161, 2020","journal-title":"Front. Pharmacol."},{"key":"3094_CR85","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1128\/JVI.79.3.1635-1644.2005","volume":"79","author":"EN van den Brink","year":"2005","unstructured":"van den Brink, E. N., J. Ter Meulen, F. Cox, M. A. Jongeneelen, A. Thijsse, M. Throsby, W. E. Marissen, P. M. Rood, A. B. Bakker, H. R. Gelderblom, B. E. Martina, A. D. Osterhaus, W. Preiser, H. W. Doerr, J. de Kruif, and J. Goudsmit. Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus. J Virol. 79:1635\u20131644, 2005","journal-title":"J Virol"},{"key":"3094_CR86","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1080\/22221751.2020.1739565","volume":"9","author":"N Vankadari","year":"2020","unstructured":"Vankadari, N., and J. A. Wilce. Emerging COVID-19 coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26. Emerg. Microb. Infect. 9:601\u2013604, 2020","journal-title":"Emerg. Microb. Infect."},{"key":"3094_CR87","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.cell.2018.12.028","volume":"176","author":"AC Walls","year":"2019","unstructured":"Walls, A. C., X. Xiong, Y. J. Park, M. A. Tortorici, J. Snijder, J. Quispe, E. Cameroni, R. Gopal, M. Dai, A. Lanzavecchia, M. Zambon, F. A. Rey, D. Corti, and D. Veesler. Unexpected receptor functional mimicry elucidates activation of coronavirus fusion. Cell. 176:1026-1039.e1015, 2019","journal-title":"Cell"},{"key":"3094_CR88","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.chom.2014.08.009","volume":"16","author":"Q Wang","year":"2014","unstructured":"Wang, Q., J. Qi, Y. Yuan, Y. Xuan, P. Han, Y. Wan, W. Ji, Y. Li, Y. Wu, J. Wang, A. Iwamoto, P. C. Y. Woo, K.-Y. Yuen, J. Yan, G. Lu, and G. F. Gao. Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26. Cell Host Microbe. 16:328\u2013337, 2014","journal-title":"Cell Host Microbe"},{"key":"3094_CR89","doi-asserted-by":"publisher","first-page":"e10088","DOI":"10.1371\/journal.pone.0010088","volume":"5","author":"RS Waterman","year":"2010","unstructured":"Waterman, R. S., S. L. Tomchuck, S. L. Henkle, and A. M. Betancourt. A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an immunosuppressive MSC2 phenotype. PLoS ONE. 5:e10088, 2010","journal-title":"PLoS ONE"},{"key":"3094_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11095-020-02851-7","volume":"37","author":"E Weisberg","year":"2020","unstructured":"Weisberg, E., A. Parent, P. L. Yang, M. Sattler, Q. Liu, Q. Liu, J. Wang, C. Meng, S. J. Buhrlage, and N. Gray. Repurposing of kinase inhibitors for treatment of COVID-19. Pharmac. Res. 37:1\u201329, 2020","journal-title":"Pharmac. Res"},{"key":"3094_CR91","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ncrna.2020.09.001","volume":"5","author":"A Widiasta","year":"2020","unstructured":"Widiasta, A., Y. Sribudiani, H. Nugrahapraja, D. Hilmanto, N. Sekarwana, and D. Rachmadi. Potential role of ACE2-related microRNAs in COVID-19-associated nephropathy. Non-coding RNA Res. 5:153\u2013166, 2020","journal-title":"Non-coding RNA Res."},{"key":"3094_CR92","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/S2213-2600(14)70291-7","volume":"3","author":"JG Wilson","year":"2015","unstructured":"Wilson, J. G., K. D. Liu, H. Zhuo, L. Caballero, M. McMillan, X. Fang, K. Cosgrove, R. Vojnik, C. S. Calfee, J.-W. Lee, A. J. Rogers, J. Levitt, J. Wiener-Kronish, E. K. Bajwa, A. Leavitt, D. McKenna, B. T. Thompson, and M. A. Matthay. Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial. Lancet Respir. Med. 3:24\u201332, 2015","journal-title":"Lancet Respir. Med"},{"key":"3094_CR93","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/s41594-020-0468-7","volume":"27","author":"AG Wrobel","year":"2020","unstructured":"Wrobel, A. G., D. J. Benton, P. Xu, C. Roustan, S. R. Martin, P. B. Rosenthal, J. J. Skehel, and S. J. Gamblin. SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects. Nat. Struct. Mol. Biol. 27:763\u2013767, 2020","journal-title":"Nat. Struct. Mol. Biol."},{"key":"3094_CR94","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3390\/v13010109","volume":"13","author":"X Xia","year":"2021","unstructured":"Xia, X. Domains and functions of spike protein in sars-cov-2 in the context of vaccine design. Viruses. 13:109, 2021","journal-title":"Viruses"},{"key":"3094_CR95","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s11684-020-0754-0","volume":"14","author":"Z Xin","year":"2020","unstructured":"Xin, Z., K. Chen, J. Zou, P. Han, J. Hao, and Z. Han. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front. Med. 14:185\u2013192, 2020","journal-title":"Front. Med."},{"key":"3094_CR96","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41368-020-0074-x","volume":"12","author":"H Xu","year":"2020","unstructured":"Xu, H., L. Zhong, J. Deng, J. Peng, H. Dan, X. Zeng, T. Li, and Q. Chen. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int. J Oral Sci. 12:8, 2020","journal-title":"Int. J Oral Sci."},{"key":"3094_CR97","doi-asserted-by":"publisher","first-page":"e0251916","DOI":"10.1371\/journal.pone.0251916","volume":"16","author":"Y Yang","year":"2021","unstructured":"Yang, Y., Z. Cai, and J. Zhang. DPP-4 inhibitors may improve the mortality of coronavirus disease 2019: a meta-analysis. PLoS ONE. 16:e0251916, 2021","journal-title":"PLoS ONE"},{"key":"3094_CR98","doi-asserted-by":"publisher","first-page":"e00940","DOI":"10.1128\/JVI.00940-20","volume":"94","author":"X Zhao","year":"2020","unstructured":"Zhao, X., D. Chen, R. Szabla, M. Zheng, G. Li, P. Du, S. Zheng, X. Li, C. Song, and R. Li. Broad and differential animal angiotensin-converting enzyme 2 receptor usage by SARS-CoV-2. J. Virol. 94:e00940, 2020","journal-title":"J. Virol."},{"key":"3094_CR99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41256-020-00135-6","volume":"5","author":"H Zhu","year":"2020","unstructured":"Zhu, H., L. Wei, and P. Niu. The novel coronavirus outbreak in Wuhan, China. Global Health Res. Policy. 5:1\u20133, 2020","journal-title":"Global Health Res. Policy"},{"key":"3094_CR100","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.cell.2020.04.035","volume":"181","author":"CGK Ziegler","year":"2020","unstructured":"Ziegler, C. G. K., S. J. Allon, S. K. Nyquist, I. M. Mbano, V. N. Miao, C. N. Tzouanas, Y. Cao, A. S. Yousif, J. Bals, B. M. Hauser, J. Feldman, C. Muus, M. H. Wadsworth, S. W. Kazer, T. K. Hughes, B. Doran, G. J. Gatter, M. Vukovic, F. Taliaferro, B. E. Mead, Z. Guo, J. P. Wang, D. Gras, M. Plaisant, M. Ansari, I. Angelidis, H. Adler, J. M. S. Sucre, C. J. Taylor, B. Lin, A. Waghray, V. Mitsialis, D. F. Dwyer, K. M. Buchheit, J. A. Boyce, N. A. Barrett, T. M. Laidlaw, S. L. Carroll, L. Colonna, V. Tkachev, C. W. Peterson, A. Yu, H. B. Zheng, H. P. Gideon, C. G. Winchell, P. L. Lin, C. D. Bingle, S. B. Snapper, J. A. Kropski, F. J. Theis, H. B. Schiller, L.-E. Zaragosi, P. Barbry, A. Leslie, H.-P. Kiem, J. L. Flynn, S. M. Fortune, B. Berger, R. W. Finberg, L. S. Kean, M. Garber, A. G. Schmidt, D. Lingwood, A. K. Shalek, J. Ordovas-Montanes, N. Banovich, P. Barbry, A. Brazma, T. Desai, T. E. Duong, O. Eickelberg, C. Falk, M. Farzan, I. Glass, M. Haniffa, P. Horvath, D. Hung, N. Kaminski, M. Krasnow, J. A. Kropski, M. Kuhnemund, R. Lafyatis, H. Lee, S. Leroy, S. Linnarson, J. Lundeberg, K. Meyer, A. Misharin, M. Nawijn, M. Z. Nikolic, J. Ordovas-Montanes, D. Pe\u2019er, J. Powell, S. Quake, J. Rajagopal, P. R. Tata, E. L. Rawlins, A. Regev, P. A. Reyfman, M. Rojas, O. Rosen, K. Saeb-Parsy, C. Samakovlis, H. Schiller, J. L. Schultze, M. A. Seibold, A. K. Shalek, D. Shepherd, J. Spence, A. Spira, X. Sun, S. Teichmann, F. Theis, A. Tsankov, M. van den Berge, M. von Papen, J. Whitsett, R. Xavier, Y. Xu, L.-E. Zaragosi, and K. Zhang. SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell. 181:1016\u20131035, 2020","journal-title":"Cell"}],"container-title":["Annals of Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10439-022-03094-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10439-022-03094-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10439-022-03094-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T18:05:13Z","timestamp":1672164313000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10439-022-03094-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,19]]},"references-count":100,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3094"],"URL":"https:\/\/doi.org\/10.1007\/s10439-022-03094-w","relation":{},"ISSN":["0090-6964","1573-9686"],"issn-type":[{"value":"0090-6964","type":"print"},{"value":"1573-9686","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,19]]},"assertion":[{"value":"31 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}